Connection

Anthony Alberg to Aged

Back to Details
This is a "connection" page, showing publications Anthony Alberg has written about Aged.
Anthony Alberg
Connection Strength
1.552
Aged
  1. Epidemiology of breast cancer in older women: implications for future healthcare. Drugs Aging. 2001; 18(10):761-72.
    View in: PubMed
    Score: 0.062
  2. A cohort study of personal and family history of skin cancer in relation to future risk of non-cutaneous malignancies. Cancer Causes Control. 2019 Nov; 30(11):1213-1221.
    View in: PubMed
    Score: 0.057
  3. Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship. Anticancer Res. 2019 Sep; 39(9):5083-5087.
    View in: PubMed
    Score: 0.057
  4. Physical and emotional well-being and support in newly diagnosed head and neck cancer patient-caregiver dyads. J Psychosoc Oncol. 2017 Nov-Dec; 35(6):646-665.
    View in: PubMed
    Score: 0.048
  5. Family history of cutaneous and noncutaneous malignancies in relation to the risk of keratinocyte carcinoma coupled with another type of cancer: A case-control study. J Am Acad Dermatol. 2016 Nov; 75(5):1066-1068.e7.
    View in: PubMed
    Score: 0.046
  6. Socioeconomic Status in Relation to the Risk of Ovarian Cancer in African-American Women: A Population-Based Case-Control Study. Am J Epidemiol. 2016 08 15; 184(4):274-83.
    View in: PubMed
    Score: 0.046
  7. Prognostic factors in relation to racial disparity in advanced colorectal cancer survival. Clin Colorectal Cancer. 2013 Dec; 12(4):287-93.
    View in: PubMed
    Score: 0.038
  8. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. Cancer Epidemiol Biomarkers Prev. 2013 Aug; 22(8):1374-82.
    View in: PubMed
    Score: 0.037
  9. Association of matrix metalloproteinase-1 polymorphisms with risk of COPD and lung cancer and survival in lung cancer. Anticancer Res. 2012 Sep; 32(9):3917-22.
    View in: PubMed
    Score: 0.035
  10. SERPINA1 and ELA2 polymorphisms are not associated with COPD or lung cancer. Anticancer Res. 2012 Sep; 32(9):3923-8.
    View in: PubMed
    Score: 0.035
  11. A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype. Carcinogenesis. 2012 Sep; 33(9):1692-8.
    View in: PubMed
    Score: 0.034
  12. A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer. J Invest Dermatol. 2012 May; 132(5):1354-62.
    View in: PubMed
    Score: 0.034
  13. Cigarette smoking and the risk of dying from tobacco-related malignancies by race. Anticancer Res. 2011 Nov; 31(11):3891-5.
    View in: PubMed
    Score: 0.033
  14. Sun-seeking behavior to increase cutaneous vitamin D synthesis: when prevention messages conflict. Public Health Rep. 2011 Jul-Aug; 126(4):533-9.
    View in: PubMed
    Score: 0.032
  15. Factors associated with cancer survivors' selection between two group physical activity programs. J Cancer Surviv. 2010 Dec; 4(4):388-98.
    View in: PubMed
    Score: 0.030
  16. Cigarette smoking and malignant melanoma: a case-control study. J Am Acad Dermatol. 2011 Jan; 64(1):84-90.
    View in: PubMed
    Score: 0.029
  17. The association between skin characteristics and skin cancer prevention behaviors. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2613-9.
    View in: PubMed
    Score: 0.028
  18. Copy number variants of GSTM1 and GSTT1 in relation to lung cancer risk in a prospective cohort study. Ann Epidemiol. 2009 Aug; 19(8):546-52.
    View in: PubMed
    Score: 0.028
  19. The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Ann Epidemiol. 2009 May; 19(5):304-10.
    View in: PubMed
    Score: 0.027
  20. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst. 2008 Sep 03; 100(17):1215-22.
    View in: PubMed
    Score: 0.026
  21. Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr. 2008 Aug; 88(2):372-83.
    View in: PubMed
    Score: 0.026
  22. A prospective cohort study of rectal cancer risk in relation to active cigarette smoking and passive smoke exposure. Ann Epidemiol. 2008 Jan; 18(1):28-35.
    View in: PubMed
    Score: 0.025
  23. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol. 2007 Mar 15; 165(6):660-6.
    View in: PubMed
    Score: 0.024
  24. Active cigarette smoking, household passive smoke exposure, and the risk of developing pancreatic cancer. Prev Med. 2006 Mar; 42(3):200-5.
    View in: PubMed
    Score: 0.022
  25. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol. 2005 Jan; 105(1):174-81.
    View in: PubMed
    Score: 0.020
  26. Nicotine replacement therapy use among a cohort of smokers. J Addict Dis. 2005; 24(1):101-13.
    View in: PubMed
    Score: 0.020
  27. The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program. Addict Behav. 2004 Dec; 29(9):1763-78.
    View in: PubMed
    Score: 0.020
  28. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev. 2004; 28(3):187-93.
    View in: PubMed
    Score: 0.019
  29. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin. Anticancer Res. 2001 Nov-Dec; 21(6A):4051-4.
    View in: PubMed
    Score: 0.016
  30. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomarkers Prev. 2000 May; 9(5):517-21.
    View in: PubMed
    Score: 0.015
  31. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):455-464.
    View in: PubMed
    Score: 0.015
  32. Cardiometabolic comorbidities and epithelial ovarian cancer risk among African-American women in the African-American Cancer Epidemiology Study (AACES). Gynecol Oncol. 2020 07; 158(1):123-129.
    View in: PubMed
    Score: 0.015
  33. Prediagnostic Proinflammatory Dietary Potential Is Associated with All-Cause Mortality among African-American Women with High-Grade Serous Ovarian Carcinoma. J Nutr. 2019 09 01; 149(9):1606-1616.
    View in: PubMed
    Score: 0.014
  34. Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study. Cancer. 2019 12 15; 125(24):4442-4451.
    View in: PubMed
    Score: 0.014
  35. Rules about smoking and vaping in the home: findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey. Addiction. 2019 10; 114 Suppl 1:107-114.
    View in: PubMed
    Score: 0.014
  36. Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES). Int J Gynecol Pathol. 2019 Mar; 38(2):157-170.
    View in: PubMed
    Score: 0.014
  37. Causal attributions and their impact on psychosocial functioning in head and neck cancer patient-caregiver dyads: a preliminary, longitudinal study. Qual Life Res. 2019 Apr; 28(4):1105-1109.
    View in: PubMed
    Score: 0.013
  38. Individual, Social, and Societal Correlates of Health-Related Quality of Life Among African American Survivors of Ovarian Cancer: Results from the African American Cancer Epidemiology Study. J Womens Health (Larchmt). 2019 02; 28(2):284-293.
    View in: PubMed
    Score: 0.013
  39. Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study. Cancer Causes Control. 2018 Nov; 29(11):1081-1091.
    View in: PubMed
    Score: 0.013
  40. Tumor-Infiltrating Lymphocytes and Colorectal Cancer Survival in African American and Caucasian Patients. Cancer Epidemiol Biomarkers Prev. 2018 07; 27(7):755-761.
    View in: PubMed
    Score: 0.013
  41. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol. 2018 04 01; 47(2):460-472.
    View in: PubMed
    Score: 0.013
  42. Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action. Papillomavirus Res. 2018 06; 5:21-31.
    View in: PubMed
    Score: 0.013
  43. Recreational physical activity and survival in African-American women with ovarian cancer. Cancer Causes Control. 2018 01; 29(1):77-86.
    View in: PubMed
    Score: 0.013
  44. Tubal ligation and ovarian cancer risk in African American women. Cancer Causes Control. 2017 Oct; 28(10):1033-1041.
    View in: PubMed
    Score: 0.012
  45. Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women. Am J Epidemiol. 2017 Jul 01; 186(1):46-53.
    View in: PubMed
    Score: 0.012
  46. Dietary Quality and Ovarian Cancer Risk in African-American Women. Am J Epidemiol. 2017 06 15; 185(12):1281-1289.
    View in: PubMed
    Score: 0.012
  47. Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women. Cancer Causes Control. 2017 May; 28(5):405-414.
    View in: PubMed
    Score: 0.012
  48. Racial Differences in Stage IV Colorectal Cancer Survival in Younger and Older Patients. Clin Colorectal Cancer. 2017 09; 16(3):178-186.
    View in: PubMed
    Score: 0.012
  49. Dairy, calcium, vitamin D and ovarian cancer risk in African-American women. Br J Cancer. 2016 Oct 25; 115(9):1122-1130.
    View in: PubMed
    Score: 0.012
  50. Reproductive factors and ovarian cancer risk in African-American women. Ann Epidemiol. 2016 09; 26(9):654-62.
    View in: PubMed
    Score: 0.011
  51. Smoking status and symptom burden in surgical head and neck cancer patients. Laryngoscope. 2017 01; 127(1):127-133.
    View in: PubMed
    Score: 0.011
  52. Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES). Cancer Epidemiol Biomarkers Prev. 2016 10; 25(10):1411-1417.
    View in: PubMed
    Score: 0.011
  53. Obesity, weight gain, and ovarian cancer risk in African American women. Int J Cancer. 2016 08 01; 139(3):593-600.
    View in: PubMed
    Score: 0.011
  54. Recreational physical activity and ovarian cancer risk in African American women. Cancer Med. 2016 06; 5(6):1319-27.
    View in: PubMed
    Score: 0.011
  55. Analgesic medication use and risk of epithelial ovarian cancer in African American women. Br J Cancer. 2016 Mar 29; 114(7):819-25.
    View in: PubMed
    Score: 0.011
  56. The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer. J Womens Health (Larchmt). 2016 Jun; 25(6):571-8.
    View in: PubMed
    Score: 0.011
  57. Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women. Br J Nutr. 2016 Feb 28; 115(4):694-702.
    View in: PubMed
    Score: 0.011
  58. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1068-74.
    View in: PubMed
    Score: 0.011
  59. Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. 2016 May; 38(5):700-6.
    View in: PubMed
    Score: 0.010
  60. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma. J Hematol Oncol. 2014 Sep 27; 7:65.
    View in: PubMed
    Score: 0.010
  61. A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES). BMC Cancer. 2014 Sep 22; 14:688.
    View in: PubMed
    Score: 0.010
  62. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer. 2011 Aug 23; 105(5):709-22.
    View in: PubMed
    Score: 0.008
  63. Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine Tob Res. 2011 Aug; 13(8):646-52.
    View in: PubMed
    Score: 0.008
  64. Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3375-83.
    View in: PubMed
    Score: 0.007
  65. Secondhand tobacco smoke exposure and chronic rhinosinusitis: a population-based case-control study. Am J Rhinol Allergy. 2009 Nov-Dec; 23(6):562-7.
    View in: PubMed
    Score: 0.007
  66. Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk. Int J Cancer. 2009 Aug 01; 125(3):674-9.
    View in: PubMed
    Score: 0.007
  67. Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):215-22.
    View in: PubMed
    Score: 0.007
  68. C-reactive protein concentrations and subsequent ovarian cancer risk. Obstet Gynecol. 2007 Apr; 109(4):933-41.
    View in: PubMed
    Score: 0.006
  69. Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology. 2007 Apr; 69(4):721-5.
    View in: PubMed
    Score: 0.006
  70. Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcohol Clin Exp Res. 2007 Mar; 31(3):467-76.
    View in: PubMed
    Score: 0.006
  71. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer. 2006 Nov 01; 107(9):2282-90.
    View in: PubMed
    Score: 0.006
  72. Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr. 2006 Sep; 43(1):47-55.
    View in: PubMed
    Score: 0.006
  73. Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients. Clin Cancer Res. 2006 Mar 01; 12(5):1564-9.
    View in: PubMed
    Score: 0.006
  74. Missing stage and grade in Maryland prostate cancer surveillance data, 1992-1997. Am J Prev Med. 2006 Feb; 30(2 Suppl):S77-87.
    View in: PubMed
    Score: 0.006
  75. Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):19-24.
    View in: PubMed
    Score: 0.005
  76. Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res. 2005 Oct 15; 65(20):9566-73.
    View in: PubMed
    Score: 0.005
  77. Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma. Int J Epidemiol. 2005 Oct; 34(5):1110-7.
    View in: PubMed
    Score: 0.005
  78. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res. 2005 Apr 01; 11(7):2486-91.
    View in: PubMed
    Score: 0.005
  79. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):633-7.
    View in: PubMed
    Score: 0.005
  80. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. J Thorac Cardiovasc Surg. 2005 Jan; 129(1):64-72.
    View in: PubMed
    Score: 0.005
  81. The role of area-level influences on prostate cancer grade and stage at diagnosis. Prev Med. 2004 Sep; 39(3):441-8.
    View in: PubMed
    Score: 0.005
  82. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis. 2004 Dec; 25(12):2467-72.
    View in: PubMed
    Score: 0.005
  83. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev. 2004 Aug; 13(8):1271-5.
    View in: PubMed
    Score: 0.005
  84. Risk of subsequent primary neoplasms developing in lung cancer patients with prior malignancies. J Thorac Cardiovasc Surg. 2004 Apr; 127(4):1119-25.
    View in: PubMed
    Score: 0.005
  85. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis. 2004 Feb 15; 189(4):686-98.
    View in: PubMed
    Score: 0.005
  86. Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience. Ann Thorac Surg. 2004 Jan; 77(1):271-7.
    View in: PubMed
    Score: 0.005
  87. Opportunities for oral cancer screening among older African-American women. Prev Med. 2003 Nov; 37(5):499-506.
    View in: PubMed
    Score: 0.005
  88. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003 Aug 20; 95(16):1218-26.
    View in: PubMed
    Score: 0.005
  89. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev. 2003 May; 12(5):460-3.
    View in: PubMed
    Score: 0.005
  90. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol. 2003 Feb 15; 157(4):335-44.
    View in: PubMed
    Score: 0.004
  91. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis. 2003 Feb; 24(2):269-74.
    View in: PubMed
    Score: 0.004
  92. A comparison of three comorbidity indexes in a head and neck cancer population. Oral Oncol. 2002 Feb; 38(2):187-94.
    View in: PubMed
    Score: 0.004
  93. The American Society of Anesthesiologists' class as a comorbidity index in a cohort of head and neck cancer surgical patients. Head Neck. 2001 Nov; 23(11):985-94.
    View in: PubMed
    Score: 0.004
  94. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000 Dec 20; 92(24):2018-23.
    View in: PubMed
    Score: 0.004
  95. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999 Jun; 8(6):525-32.
    View in: PubMed
    Score: 0.003
  96. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev. 1997 Nov; 6(11):907-16.
    View in: PubMed
    Score: 0.003
  97. Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. Cancer Epidemiol Biomarkers Prev. 1997 Apr; 6(4):233-7.
    View in: PubMed
    Score: 0.003
  98. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA. 1995 Dec 27; 274(24):1926-30.
    View in: PubMed
    Score: 0.003
  99. Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, beta- carotene, lycopene, alpha-tocopherol, and selenium. Cancer Epidemiol Biomarkers Prev. 1995 Dec; 4(8):837-42.
    View in: PubMed
    Score: 0.003
  100. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994; 18(2):79-85.
    View in: PubMed
    Score: 0.002
  101. Prospective study of serum CA-125 levels as markers of ovarian cancer. JAMA. 1993 Mar 03; 269(9):1123-6.
    View in: PubMed
    Score: 0.002
  102. Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb; 2(1):33-5.
    View in: PubMed
    Score: 0.002
  103. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res. 1992 Jan 01; 52(1):1-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.